method, in accordance with the criteria proposed by the Clinical and Laboratory Standards
Institute (CLSI) [5 ]. The following antimicrobial
agents were used: ampicillin (FUJIFILM Wako Pure Chemical Corp., Osaka, Japan), oxacillin
(Sigma-Aldrich, St. Louis, MO, USA), cephalexin (Tokyo Chemical Industry Co., Ltd., Tokyo,
Japan), imipenem (FUJIFILM Wako), fosfomycin (Sigma-Aldrich), enrofloxacin (Tokyo Chemical
Industry), levofloxacin (FUJIFILM Wako), erythromycin (Sigma-Aldrich), lincomycin
(Sigma-Aldrich), gentamicin (FUJIFILM Wako), minocycline (FUJIFILM Wako), chloramphenicol
(FUJIFILM Wako), and vancomycin (FUJIFILM Wako). The breakpoints of these antimicrobial
agents were determined using the interpretation criteria proposed by the CLSI [6 ].